Axsome Therapeutics(DE:19X)
€133.80+10.75 (+8.74%)
DE:19X
Axsome Therapeutics Revenue
€133.80
At close:+10.75 (+8.74%)
Axsome Therapeutics (19X) Revenue
5 Followers
Axsome Therapeutics Revenue
Axsome Therapeutics had a revenue of 259.69M in the quarter ending Sep 30, 2026, with 18.92%. This bring the company's revenue in the last twelve months to 865.27M, Increased 11.42%. In the fiscal year ending Dec 31, 2025, Axsome Therapeutics had annual revenue of 638.50M with 65.55% growth.
- Revenue (ttm)
- 865.27M
- Revenue Growth
- 47.47%
- P/S Ratio
- 10.47
- Revenue/Employee
- EUR 474,366
- Employees
- 1,346
- Market Cap
- EUR 6.68B
Revenue Chart
Axsome Therapeutics Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 638.50M | 252.80M | 65.55% |
| Dec 31, 2024 | 385.69M | 115.09M | 42.53% |
| Dec 31, 2023 | 270.60M | 220.56M | 440.80% |
| Dec 31, 2022 | 50.04M | 50.04M | ― |
| Dec 31, 2021 | 0.00 | 0.00 | ― |
| Dec 31, 2020 | 0.00 | 0.00 | ― |
| Dec 31, 2019 | 0.00 | 0.00 | ― |
| Dec 31, 2018 | 0.00 | 0.00 | ― |
| Dec 31, 2017 | 0.00 | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.